scholarly journals Quality of Life After Combined Cataract and Minimally Invasive Glaucoma Surgery in Glaucoma Patients

2020 ◽  
Vol Volume 14 ◽  
pp. 3049-3056
Author(s):  
Ahmed Al Habash ◽  
Ahmed A Nagshbandi
2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Lívia M. Brandão ◽  
Matthias C. Grieshaber

Traditional glaucoma surgery has been challenged by the advent of innovative techniques and new implants in the past few years. There is an increasing demand for safer glaucoma surgery offering patients a timely surgical solution in reducing intraocular pressure (IOP) and improving their quality of life. The new procedures and devices aim to lower IOP with a higher safety profile than fistulating surgery (trabeculectomy/drainage tubes) and are collectively termed “minimally invasive glaucoma surgery (MIGS).” The main advantage of MIGS is that they are nonpenetrating and/or bleb-independent procedures, thus avoiding the major complications of fistulating surgery related to blebs and hypotony. In this review, the clinical results of the latest techniques and devices are presented by their approach, ab interno (trabeculotomy, excimer laser trabeculotomy, trabecular microbypass, suprachoroidal shunt, and intracanalicular scaffold) and ab externo (canaloplasty, Stegmann Canal Expander, suprachoroidal Gold microshunt). The drawback of MIGS is that some of these procedures produce a limited IOP reduction compared to trabeculectomy. Currently, MIGS is performed in glaucoma patients with early to moderate disease and preferably in combination with cataract surgery.


Author(s):  
Chelvin C. A. Sng ◽  
Clement C. Tham ◽  
Donald L. Budenz ◽  
Paul R. Healey ◽  
Ningli Wang

Abstract Globalization is a comprehensive phenomenon with significant implications for global health. The globalization of minimally invasive glaucoma surgery (MIGS) is currently still a work in progress, with these devices slowly making inroads into Asia, Australasia, South America, and South Africa. Although MIGS companies can enjoy a quantum leap in economies of scale by serving global markets rather than only a confined domestic market, there are considerable economic, logistical, training, legal, and regulatory challenges that they need to overcome. The globalization of MIGS may benefit glaucoma patients worldwide, by reducing medication burden, improving the quality of life, and potentially decreasing the global incidence of glaucoma-related blindness.


2011 ◽  
Vol 26 (1) ◽  
pp. 168-176 ◽  
Author(s):  
Abhishek Sundaram ◽  
Juan C. Geronimo ◽  
Brittany L. Willer ◽  
Masato Hoshino ◽  
Zachary Torgersen ◽  
...  

2014 ◽  
pp. 7 ◽  
Author(s):  
Juliane Matlach ◽  
Johannes Sauer ◽  
Norbert Körber ◽  
Franz Grehn ◽  
Martin Much ◽  
...  

2015 ◽  
Vol 30 (3) ◽  
pp. 1184-1187 ◽  
Author(s):  
Maria Verseveld ◽  
Renée M. Barendse ◽  
Martijn P. Gosselink ◽  
Cornelis Verhoef ◽  
Eelco J. R. de Graaf ◽  
...  

Author(s):  
J. García-Feijóo ◽  
J.M. Larrosa ◽  
J.M. Martínez-de-la-Casa ◽  
V. Polo ◽  
L.P. Julvez

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Peter Chang ◽  
Jialin Mao ◽  
Kimberly Taylor ◽  
Ostap Dovirak ◽  
Arie Carneiro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document